key: cord-0755537-ux8xhf4j authors: Castagna, Francesco; Cerrud‐Rodriguez, Roberto; Villela, Miguel Alvarez; Bortnick, Anna E. title: SARS‐COV‐2 infection presenting as ST‐elevationmyocardial infarction date: 2020-05-30 journal: Catheter Cardiovasc Interv DOI: 10.1002/ccd.28974 sha: 7c3358cf362a0fa1b05bb674adfffa1fc08c5dab doc_id: 755537 cord_uid: ux8xhf4j We describe a patient presenting with chest discomfort, anterolateral ST elevation, and developing acute cardiogenic shock secondary to SARS‐COV‐2infection—patient zero presenting to our institution's cardiac catheterization laboratory. The emergent presentation with limited clinical information led to exposure of personnel. The diagnosis was complicated by two negative tests for SARS‐COV‐2, and high‐clinical suspicion from the patient's occupational history led to additional testing in order to confirm the diagnosis. Cardiac manifestations of SARS-COV-2 are poorly understood, but early data suggest that individuals infected with the novel pathogen responsible for the COVID-19 pandemic are susceptible to myocarditis. 1 Cardiac catheterization laboratories are on the front lines for patients presenting with emergent cardiac syndromes and must be alert to extrapulmonary presentations of SARS-COV-2. A 51-year-old man, a customer service representative at an international airport, presented to an outside hospital Emergency Department (ED) with 4 days of malaise, progressing to left-sided, non-radiating chest pain, diaphoresis and syncope with fall. His presenting vital signs were: 98 F, 181/100 mmHg, 100 beats per minute, respiratory rate 20 breaths/min, oxygen saturation 95% on room air and he had a normal physical examination. The electrocardiogram (EKG) was concerning and tachycardic (110 beats per minute), with mild cough. Bilateral interstitial prominence, consistent with possible pneumonia, was seen on chest X ray. The past medical history was significant for hypertension and hypercholesterolemia. Six weeks prior to the current presentation, he had visited another ED. He reports being told that he had a "heart attack" and that he was treated with unspecified medication. He ran out of prescriptions for 2 weeks prior to the presentation, could not report which medications he was prescribed, and was only taking aspirin and ibuprofen. He had traveled to three different boroughs of New York City during that time. The differential diagnosis included sepsis, myocarditis, and due to occupational history, SARS-COV-2. Initial laboratory testing was remarkable for hyponatremia (Table 1) . 1 Other early reports from the region indicate that patients admitted to Abbreviations: CK-MB, Creatine kinase-myocardial b fraction; CTA, computed tomography angiography; ECMO, extracorporeal membrane oxygenation; LVEF, left ventricular ejection fraction; NT pro-BNP, N-terminal pro-B-type natriuretic peptide; NA, not applicable. Clinical features of patients infected with 2019 novel coronavirus in Wuhan A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19 Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China COVID-19 and the cardiovascular system A call to action: the need for autopsies to determine the full extent of organ involvement associated with COVID-19 infections COVID-19 autopsies, Oklahoma, USA Myocardial localization of coronavirus in COVID-19 cardiogenic shock Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from ACC's interventional council and SCAI SARS-COV-2 infection presenting as ST-elevationmyocardial infarction